188 related articles for article (PubMed ID: 6304498)
1. Progression of the transformed phenotype in clonal lines of Abelson virus-infected lymphocytes.
Whitlock CA; Ziegler SF; Witte ON
Mol Cell Biol; 1983 Apr; 3(4):596-604. PubMed ID: 6304498
[TBL] [Abstract][Full Text] [Related]
2. Abelson virus-infected cells can exhibit restricted in vitro growth and low oncogenic potential.
Whitlock CA; Witte ON
J Virol; 1981 Nov; 40(2):577-84. PubMed ID: 6275106
[TBL] [Abstract][Full Text] [Related]
3. Nonrandom cytogenetic changes accompany malignant progression in clonal lines abelson virus-infected lymphocytes.
Clark SS; Liang Y; Reedstrom CK; Wu SQ
Blood; 1994 Dec; 84(12):4301-9. PubMed ID: 7994046
[TBL] [Abstract][Full Text] [Related]
4. Clonal dominance and progression in Abelson murine leukemia virus lymphomagenesis.
Green PL; Kaehler DA; Risser R
J Virol; 1987 Jul; 61(7):2192-7. PubMed ID: 3035219
[TBL] [Abstract][Full Text] [Related]
5. Abelson murine leukemia virus transformation-defective mutants with impaired P120-associated protein kinase activity.
Reynolds FH; Van de Ven WJ; Stephenson JR
J Virol; 1980 Nov; 36(2):374-86. PubMed ID: 6253663
[TBL] [Abstract][Full Text] [Related]
6. Multistage progression of Abelson virus-infected murine pre-B-cells to the tumorigenic state.
Palumbo GJ; Ozanne BW; Kettman JR
Cancer Res; 1990 Mar; 50(6):1917-23. PubMed ID: 2155061
[TBL] [Abstract][Full Text] [Related]
7. Abelson murine leukemia virus mutants deficient in kinase activity and lymphoid cell transformation.
Rosenberg NE; Clark DR; Witte ON
J Virol; 1980 Dec; 36(3):766-74. PubMed ID: 6257926
[TBL] [Abstract][Full Text] [Related]
8. Molecular and cellular biology of Abelson virus transformation.
Witte ON
Curr Top Microbiol Immunol; 1983; 103():127-46. PubMed ID: 6303708
[No Abstract] [Full Text] [Related]
9. Friend murine leukemia virus-immortalized myeloid cells are converted into tumorigenic cell lines by Abelson leukemia virus.
Oliff A; Agranovsky O; McKinney MD; Murty VV; Bauchwitz R
Proc Natl Acad Sci U S A; 1985 May; 82(10):3306-10. PubMed ID: 2987918
[TBL] [Abstract][Full Text] [Related]
10. The complexity of virus--cell interactions in Abelson virus infection of lymphoid and other hematopoietic cells.
Whitlock CA; Witte ON
Adv Immunol; 1985; 37():73-98. PubMed ID: 2988306
[No Abstract] [Full Text] [Related]
11. Malignant transformation of a growth factor-dependent myeloid cell line by Abelson virus without evidence of an autocrine mechanism.
Cook WD; Metcalf D; Nicola NA; Burgess AW; Walker F
Cell; 1985 Jul; 41(3):677-83. PubMed ID: 2988782
[TBL] [Abstract][Full Text] [Related]
12. Abelson leukemia virus.
Rosenberg N
Curr Top Microbiol Immunol; 1982; 101():95-126. PubMed ID: 6303705
[No Abstract] [Full Text] [Related]
13. Abelson murine leukemia virus-induced tumors elicit antibodies against a host cell protein, P50.
Rotter V; Witte ON; Coffman R; Baltimore D
J Virol; 1980 Nov; 36(2):547-55. PubMed ID: 6159484
[TBL] [Abstract][Full Text] [Related]
14. Protein stabilization explains the gag requirement for transformation of lymphoid cells by Abelson murine leukemia virus.
Prywes R; Hoag J; Rosenberg N; Baltimore D
J Virol; 1985 Apr; 54(1):123-32. PubMed ID: 2983109
[TBL] [Abstract][Full Text] [Related]
15. Abelson murine leukemia virus variants with increased oncogenic potential.
Murtagh K; Skladany G; Hoag J; Rosenberg N
J Virol; 1986 Nov; 60(2):599-606. PubMed ID: 3021994
[TBL] [Abstract][Full Text] [Related]
16. Neoplastic transformation of mast cells by Abelson-MuLV: abrogation of IL-3 dependence by a nonautocrine mechanism.
Pierce JH; Di Fiore PP; Aaronson SA; Potter M; Pumphrey J; Scott A; Ihle JN
Cell; 1985 Jul; 41(3):685-93. PubMed ID: 2988783
[TBL] [Abstract][Full Text] [Related]
17. Mutation of Tp53 contributes to the malignant phenotype of Abelson virus-transformed lymphoid cells.
Thome KC; Radfar A; Rosenberg N
J Virol; 1997 Nov; 71(11):8149-56. PubMed ID: 9343165
[TBL] [Abstract][Full Text] [Related]
18. In vitro transformation of murine pro-B and pre-B cells by v-mpl, a truncated form of a cytokine receptor.
Fichelson S; Vigon I; Dusanter I; Charon M; Velu T; Baillou C; Gisselbrecht S; Lemoine FM
J Immunol; 1995 Feb; 154(4):1577-86. PubMed ID: 7836743
[TBL] [Abstract][Full Text] [Related]
19. Transformation of bone marrow cells from E mu-myc transgenic mice by Abelson murine leukemia virus and Harvey murine sarcoma virus.
Dyall-Smith D; Cory S
Oncogene Res; 1988 May; 2(4):403-9. PubMed ID: 2840624
[TBL] [Abstract][Full Text] [Related]
20. Some lymphoid cell lines transformed by Abelson murine leukemia virus lack a major 36,000-dalton tyrosine protein kinase substrate.
Sefton BM; Hunter T; Cooper JA
Mol Cell Biol; 1983 Jan; 3(1):56-63. PubMed ID: 6298608
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
